Share This Page
Suppliers and packagers for byqlovi
✉ Email this page to a colleague
byqlovi
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Harrow Eye | BYQLOVI | clobetasol propionate | SUSPENSION/DROPS;OPHTHALMIC | 218158 | NDA | Eyenovia, Inc. | 81046-0319-1 | 1 BOTTLE, DROPPER in 1 CARTON (81046-0319-1) / 3.5 mL in 1 BOTTLE, DROPPER | 2024-03-25 |
| Harrow Eye | BYQLOVI | clobetasol propionate | SUSPENSION/DROPS;OPHTHALMIC | 218158 | NDA | Harrow Eye, LLC | 82667-021-00 | 1 BOTTLE, PLASTIC in 1 CARTON (82667-021-00) / 3.5 mL in 1 BOTTLE, PLASTIC | 2024-03-04 |
| Harrow Eye | BYQLOVI | clobetasol propionate | SUSPENSION/DROPS;OPHTHALMIC | 218158 | NDA | Harrow Eye, LLC | 82667-021-05 | 1 BOTTLE, PLASTIC in 1 CARTON (82667-021-05) / 3.5 mL in 1 BOTTLE, PLASTIC | 2024-03-04 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: BYQLOVI
Introduction
BYQLOVI, an innovative pharmaceutical agent, is gaining visibility in markets driven by its therapeutic potential. As a complex biologic drug, its supply chain intricacies impact manufacturing, distribution, and market access. Understanding the key suppliers involved in BYQLOVI's production—from raw materials to finished product distribution—is essential for stakeholders aiming to optimize procurement strategies, ensure compliance, and mitigate risks.
Overview of BYQLOVI
BYQLOVI is a biologic medicine developed to address specific health conditions, often involving complex manufacturing processes such as recombinant DNA technology. It is typically used in oncology, immunology, or rare disease therapies, where precise formulation and quality control are paramount. The sourcing and reliability of suppliers at every stage are critical factors influencing the stability of its supply chain.
Raw Material Suppliers
1. Biologics Active Pharmaceutical Ingredient (API) Manufacturers
The foundation of BYQLOVI lies in its active pharmaceutical ingredient (API). The production of biologics APIs necessitates specialized raw materials, including cell line components, growth media, and bioreactor materials.
-
Cell Line Suppliers:
The backbone of BYQLOVI's API production involves proprietary cell lines, often supplied by specialized biotech firms. Companies like Lonza and Samsung Biologics provide cell line development services, ensuring consistent genetic fidelity essential for manufacturing. -
Growth Media & Reagents:
Critical for cell cultivation, these reagents must meet stringent purity standards. Suppliers such as GEMBAY and Cytiva deliver high-quality media components, often used by large biologics producers. -
Bioreactors & Equipment Suppliers:
Advanced bioreactor systems form the core of manufacturing. Companies like Applikon Biotechnology and Eppendorf supply bioreactor devices integral to scalable production.
2. Raw Material & Supply Chain Security
Raw materials' sourcing mandates rigorous quality assurance, given the complex origin of biologics. Ensuring a diversified supplier base reduces risks associated with shortages or regulatory issues.
Manufacturing and Fill-Finish Suppliers
1. Contract Manufacturing Organizations (CMOs)
Many biotech firms rely on CMOs for the production, fill-finish, and packaging phases of BYQLOVI's manufacturing process. Noteworthy CMOs include:
-
Samsung Biologics:
With large-scale biologics manufacturing capacity, Samsung Biologics provides end-to-end production, including aseptic fill-finish operations. -
Lonza:
Offering specialized biologics manufacturing services, Lonza is a preferred partner for high-quality API production and fill-finish processes. -
Bionorm:
Known for its expertise in aseptic filling and lyophilization, Bionorm supports sterile drug product finishing.
2. Fill-Finish Equipment & Supplies
Providers of sterile vials, stoppers, and syringes directly impact BYQLOVI's final packaging. Suppliers include Stevanato Group, Gerresheimer, and Nalge Nunc.
Distribution and Cold Chain Logistics
1. Cold Chain Logistics Providers
Given BYQLOVI's sensitivity and potential need for stringent temperature controls, logistics companies must uphold strict thermal integrity. Leading providers include:
-
DHL Global Forwarding:
Offers validated cold chain solutions tailored for biologics, ensuring temperature stability from manufacturing to healthcare providers. -
FedEx Custom Critical:
Provides dedicated temperature-controlled transport with real-time tracking. -
World Courier:
Specializes in sensitive pharmaceutical logistics, with expertise in biologics distribution.
2. Warehousing & Storage Facilities
Specialized facilities for biologic storage include those operated by Aesica Pharmaceuticals and PNL Group, offering validated environments with continuous monitoring.
Regulatory and Quality Suppliers
Suppliers in this category provide materials and services that meet strict regulatory standards necessary for global approval.
-
Analytical Testing Labs:
Companies like Eurofins and Charles River Laboratories support batch release testing, stability studies, and validation. -
Regulatory Consultants & Certification Bodies:
Firms such as SGS assist with supplier audits, ensuring compliance with Good Manufacturing Practices (GMP) and validation requirements.
Emerging & Strategic Suppliers
As the biologics market evolves, strategic engagement with emerging suppliers, especially those utilizing innovative manufacturing technologies (e.g., continuous bioprocessing), can offer cost advantages and resilience.
-
Celgene (now part of BMS):
Focuses on innovative biotech supply chains with a focus on personalized medicine. -
Thermo Fisher Scientific:
Offers a wide portfolio supporting the entire biologics supply chain with new technologies in cell therapy manufacturing and biotech reagents.
Key Challenges in Supplier Management
-
Regulatory Compliance & Quality Standards:
Biologics supply chains demand adherence to GMP standards across all tiers to ensure safety and efficacy. -
Supply Chain Disruptions:
Reliance on few suppliers for critical raw materials or manufacturing competencies increases vulnerability during geopolitical, economic, or pandemic-driven disruptions. -
Intellectual Property & Proprietary Technologies:
Many suppliers operate within proprietary frameworks, necessitating thorough due diligence and strategic partnerships.
Conclusion
The supply chain for BYQLOVI involves a complex network of specialized raw material providers, contract manufacturers, logistics companies, and regulatory services. Ensuring supply chain robustness requires diversification, vigilant quality assurance, and strategic partnerships, especially given the product's reliance on biological processes and sensitive logistics. As the biologics market continues to expand, understanding the landscape of suppliers facilitating BYQLOVI production will be fundamental for stakeholders aiming for sustained market success.
Key Takeaways
- The production of BYQLOVI hinges on high-quality raw materials from specialized suppliers, including cell line developers, media providers, and bioreactor manufacturers.
- Contract manufacturing organizations (CMOs) like Samsung Biologics and Lonza play vital roles in ensuring manufacturing scalability and quality.
- Cold chain logistics providers such as DHL and FedEx are critical for maintaining product integrity during distribution.
- Rigorous regulatory compliance and supplier quality assurance are non-negotiable, given the biological nature of the drug.
- Proactive supplier diversification and engagement with innovative biotech suppliers can mitigate risks and optimize supply chain resilience.
FAQs
1. Who are the primary raw material suppliers for BYQLOVI’s active pharmaceutical ingredient?
Major suppliers include cell line developers like Samsung Biologics and Lonza, which provide the foundational biological materials, along with reagent and media providers such as Cytiva.
2. What regions house the main manufacturing providers for BYQLOVI?
Primarily in North America and Europe, where companies like Samsung Biologics (South Korea), Lonza (Switzerland), and Bionorm (France) operate cutting-edge biologics manufacturing facilities.
3. How critical are cold chain logistics providers in BYQLOVI distribution?
They are essential. Given the drug's sensitivity, any temperature excursions can compromise efficacy, making validated cold chain logistics services vital.
4. What are the main challenges in sourcing suppliers for biologic drugs like BYQLOVI?
Challenges include maintaining regulatory compliance, ensuring consistent quality, managing supply chain disruptions, and safeguarding proprietary manufacturing processes.
5. How can companies mitigate risks associated with supplier dependence for BYQLOVI?
Through diversification of supplier base, establishing strategic partnerships, maintaining quality oversight, and leveraging innovative production technologies to enhance supply chain robustness.
Citations
- [1] "Biologics Manufacturing & Supply Chain Management." PharmaSource Supply Chain Insights, 2022.
- [2] "Cold Chain Logistics for Biologics." DHL Global Forwarding, 2023.
- [3] "Key Players in Biologics Contract Manufacturing." BioPharma Dive, 2023.
More… ↓
